Literature DB >> 23171279

Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells.

Chang-Liang He1, Peng-Fei Yi, Qiao-Jia Fan, Hai-Qing Shen, Xiao-Lin Jiang, Qian-Qian Qin, Zhou Song, Cui Zhang, Shuai-Cheng Wu, Xu-Bin Wei, Ying-Lun Li, Ben-Dong Fu.   

Abstract

Xiang-Qi-Tang (XQT) is a Chinese herbal formula containing Cyperus rotundus, Astragalus membranaceus and Andrographis paniculata. Alpha-Cyperone (CYP), astragaloside IV (AS-IV) and andrographolide (AND) are the three major active components in this formula. XQT may modulate the inflammatory or coagulant responses. We therefore assessed the effects of XQT on lipopolysaccharide (LPS)-induced inflammatory model of rat cardiac microvascular endothelial cells (RCMECs). XQT, CYP, AS-IV and AND inhibited the production of tumor necrosis factor alpha (TNF-α), intercellular cell adhesion molecule-1 (ICAM-1) and plasminogen activator inhibitor-1 (PAI-1), and up-regulated the mRNA expression of Kruppel-like factor 2 (KLF2). XQT and CYP inhibited the secretion of tissue factor (TF). To further explore the mechanism, we found that XQT, or its active components CYP, AS-IV and AND significantly inhibited extracellular signal-regulated kinase (ERK), c-jun NH2-terminal kinase (JNK) and p38 phosphorylation protein expression as well as decreased the phosphorylation levels of nuclear factor κB (NF-κB) p65 proteins in LPS-stimulated RCMECs. These results suggested that XQT and its active components inhibited the expression of inflammatory and coagulant mediators via mitogen-activated protein kinase (MAPKs) and NF-κB signaling pathways. These findings may contribute to future research on the action mechanisms of this formula, as well as therapy for inflammation- or coagulation-related diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23171279     DOI: 10.3109/08923973.2012.744034

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  8 in total

Review 1.  Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients.

Authors:  Sizheng Zhao; Fred Otieno; Asan Akpan; Robert J Moots
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

2.  Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway.

Authors:  Xin Xie; Meng-Yao Wu; Liu-Mei Shou; Long-Pei Chen; Fei-Ran Gong; Kai Chen; Dao-Ming Li; Wei-Ming Duan; Yu-Feng Xie; Yi-Xiang Mao; Wei Li; Min Tao
Journal:  Oncol Lett       Date:  2014-11-19       Impact factor: 2.967

3.  Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside-induced nephrosis by suppressing inflammation and apoptosis.

Authors:  Yumin Wen; Yongli Zhan; Huijie Liu; Tingting Zhao; Liping Yang; Haojun Zhang; Xi Dong; Ping Li
Journal:  BMC Complement Altern Med       Date:  2015-05-27       Impact factor: 3.659

4.  The Role of Endophytic/Epiphytic Bacterial Constituents in the Immunostimulatory Activity of the Botanical, Astragalus membranaceus.

Authors:  Heather Koehler; Keely Puchalski; Guillermo Ruiz; Bertram Jacobs; Jeffrey Langland
Journal:  Yale J Biol Med       Date:  2020-06-29

5.  Beneficial effects of andrographolide in a rat model of autoimmune myocarditis and its effects on PI3K/Akt pathway.

Authors:  Qi Zhang; Li-Qun Hu; Hong-Qi Li; Jun Wu; Na-Na Bian; Guang Yan
Journal:  Korean J Physiol Pharmacol       Date:  2019-02-15       Impact factor: 2.016

Review 6.  Study on the mechanism of andrographolide activation.

Authors:  Qihan Cai; Weina Zhang; Yanan Sun; Lu Xu; Mengmeng Wang; Xinliang Wang; Siming Wang; Zhiyu Ni
Journal:  Front Neurosci       Date:  2022-09-13       Impact factor: 5.152

7.  Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.

Authors:  Ting Wu; Haiyan Chu; Wenzhen Tu; Mengmeng Song; Dongdong Chen; Jin Yuan; Ling Yu; Yanyun Ma; Qingmei Liu; Li Jin; Xiaodong Zhou; Hejian Zou; Wenyu Wu; Jiucun Wang
Journal:  BMC Complement Altern Med       Date:  2014-07-07       Impact factor: 3.659

8.  Caffeoylxanthiazonoside exerts cardioprotective effects during chronic heart failure via inhibition of inflammatory responses in cardiac cells.

Authors:  Bin Yang; Fei Wang; Huili Cao; Guifang Liu; Yuean Zhang; Ping Yan; Bao Li
Journal:  Exp Ther Med       Date:  2017-08-31       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.